drugset / Trial / NCT04517110

Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery

NCT04517110

RandomizedParallel-groupQuadruple-blindTreatment

Summary

OPIATE is a double-blinded randomized controlled trial (RCT) comparing pregabalin in addition to usual care to usual care alone for reducing post-operative opioid consumption in patients undergoing on-pump cardiac surgery. Patients will be randomized in a 1:1 ratio to receive either pregabalin (300 mg pre-operatively + 75 mg post-operatively twice daily until discharge or 5 days) in addition to usual care or matching placebos in addition to usual care. The aim of the trial is to show that pregabalin is superior to usual care (i.e. a superiority trial).

Timeline

Start
2021-04-09
Primary completion
2022-09-07
Completion
2022-09-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral
Subject Pregabalin Small molecule 300 mg Oral